Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (35)
Pouya Mahdavi Sharif, Amin Pastaki Khoshbin, Elaheh Nasrollahzadeh, Mahsa Keshavarz-Fathi & Nima Rezaei. 2023. Clinical Immunology. Clinical Immunology
245
452
.
Mehmet SÖZEN, Zeynep CANTÜRK, Alev SELEK, Berrin ÇETİNASLAN, Burcu SEVİNÇ, Emre GEZER & Damla KÖKSALAN. (2022) EVALUATION OF INFLAMMATION-RELATED HEMOGRAM PARAMETERS AS A USEFUL MARKER IN PAPILLARY THYROID CARCINOMAPAPİLLER TİROİD KARSİNOMUNDA YARARLI BİR BELİRTEÇ OLARAK İNFLAMASYONLA İLİŞKİLİ HEMOGRAM PARAMETRELERİNİN DEĞERLENDİRİLMESİ. SDÜ Tıp Fakültesi Dergisi 29:4, pages 611-618.
Crossref
Crossref
Elise Amblard & Vassili Soumelis. (2022) Context-Dependent Effects Explain Divergent Prognostic Roles of Tregs in Cancer. Cancers 14:12, pages 2991.
Crossref
Crossref
Smitha Sammith Shetty, Kanaka Sai Ram Padam, Keith D. Hunter, Adarsh Kudva & Raghu Radhakrishnan. (2022) Biological implications of the immune factors in the tumour microenvironment of oral cancer. Archives of Oral Biology 133, pages 105294.
Crossref
Crossref
Elisabeth Wik, Lise M. Ingebriktsen & Lars A. Akslen. 2022. Biomarkers of the Tumor Microenvironment. Biomarkers of the Tumor Microenvironment
401
424
.
Zhen Lin, Yi-Zhao Xie, Ming-Chun Zhao, Pin-Pin Hou, Juan Tang & Guang-Liang Chen. (2021) Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma. Cancer Cell International 21:1.
Crossref
Crossref
Dina Guo, Mian Wang, Zhihong Shen & Jiaona Zhu. (2020) A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma. Journal of Translational Medicine 18:1.
Crossref
Crossref
Pallab Datta, Madhuri Dey, Zaman Ataie, Derya Unutmaz & Ibrahim T. Ozbolat. (2020) 3D bioprinting for reconstituting the cancer microenvironment. npj Precision Oncology 4:1.
Crossref
Crossref
Simon P Keam, Heloise Halse, Thu Nguyen, Minyu Wang, Nicolas Van Kooten Losio, Catherine Mitchell, Franco Caramia, David J Byrne, Sue Haupt, Georgina Ryland, Phillip K Darcy, Shahneen Sandhu, Piers Blombery, Ygal Haupt, Scott G Williams & Paul J Neeson. (2020) High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot. Journal for ImmunoTherapy of Cancer 8:1, pages e000792.
Crossref
Crossref
Florian Guisier, Mateus Camargo Barros-Filho, Leigha D. Rock, Megan Strachan-Whaley, Erin A. Marshall, Graham Dellaire & Wan L. Lam. 2020. Tumor Microenvironment. Tumor Microenvironment
35
51
.
Laura Croce, Francesca Coperchini, Flavia Magri, Luca Chiovato & Mario Rotondi. (2019) The multifaceted anti-cancer effects of BRAF-inhibitors. Oncotarget 10:61, pages 6623-6640.
Crossref
Crossref
Cui-Ying Zhang, Juan Zhang, Yun-Fan Ma, Hong Zhe, Ren Zhao & Yan-Yang Wang. (2019) Prognostic Value of Combined Analysis of CTLA-4 and PLR in Esophageal Squamous Cell Carcinoma (ESCC) Patients. Disease Markers 2019, pages 1-7.
Crossref
Crossref
Milly J. McAllister, Mark A. Underwood, Hing Y. Leung & Joanne Edwards. (2019) A review on the interactions between the tumor microenvironment and androgen receptor signaling in prostate cancer. Translational Research 206, pages 91-106.
Crossref
Crossref
Patrick Danaher, Sarah Warren, Rongze Lu, Josue Samayoa, Amy Sullivan, Irena Pekker, Brett Wallden, Francesco M. Marincola & Alessandra Cesano. (2018) Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA). Journal for ImmunoTherapy of Cancer 6:1.
Crossref
Crossref
Mary Frances Wedekind, Kellie B. Haworth, Michael Arnold, Joseph R. Stanek, Dean Lee & Timothy P. Cripe. (2018) Immune profiles of desmoplastic small round cell tumor and synovial sarcoma suggest different immunotherapeutic susceptibility upfront compared to relapse specimens. Pediatric Blood & Cancer 65:11, pages e27313.
Crossref
Crossref
Mario Rotondi, Francesca Coperchini, Francesco Latrofa & Luca Chiovato. (2018) Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player?. Frontiers in Endocrinology 9.
Crossref
Crossref
Yasmin A. Lyons, Sherry Y. Wu, Willem W. Overwijk, Keith A. Baggerly & Anil K. Sood. (2017) Immune cell profiling in cancer: molecular approaches to cell-specific identification. npj Precision Oncology 1:1.
Crossref
Crossref
Soheil Tavakolpour, Maryam Daneshpazhooh & HamidReza Mahmoudi. 2017. Cancer Genetics and Psychotherapy. Cancer Genetics and Psychotherapy
851
934
.
Elisabeth Wik & Lars A. Akslen. 2017. Biomarkers of the Tumor Microenvironment. Biomarkers of the Tumor Microenvironment
379
407
.
Jessica G. Cockburn, Robin M. Hallett, Amy E. Gillgrass, Kay N. Dias, T. Whelan, M. N. Levine, John A. Hassell & Anita Bane. (2016) The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures. BMC Cancer 16:1.
Crossref
Crossref
David I. Quinn, Neal D. Shore, Shin Egawa, Winald R. Gerritsen & Karim Fizazi. (2015) Immunotherapy for castration-resistant prostate cancer: Progress and new paradigms. Urologic Oncology: Seminars and Original Investigations 33:5, pages 245-260.
Crossref
Crossref
Paul T. Spellman, Josh Stuart & Joe W. Gray. 2015. The Molecular Basis of Cancer. The Molecular Basis of Cancer
357
368.e3
.
Lucas Leite Cunha, Marjory Alana Marcello & Laura Sterian Ward. (2014) The role of the inflammatory microenvironment in thyroid carcinogenesis. Endocrine-Related Cancer 21:3, pages R85-R103.
Crossref
Crossref
Elise P. Salerno, Walter C. Olson, Chantel McSkimming, Sofia Shea & Craig L. SlingluffJr.Jr.. (2014) T cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrins. International Journal of Cancer 134:3, pages 563-574.
Crossref
Crossref
Alexandra Snyder, Jaron E. Tepper & Susan F. Slovin. (2013) Perspectives on Immunotherapy in Prostate Cancer and Solid Tumors: Where Is the Future?. Seminars in Oncology 40:3, pages 347-360.
Crossref
Crossref
Michael A. MorseTakuya OsadaAmy HobeikaSandip PatelH. Kim Lyerly. (2013) Biomarkers and Correlative Endpoints for Immunotherapy Trials: What Can We Learn in Lung Cancer from Other Tumor Types?. American Society of Clinical Oncology Educational Book:33, pages e287-e293.
Crossref
Crossref
Matthew D. Morse & Douglas G. McNeel. (2011)
T cells localized to the androgen‐deprived prostate are T
H
1 and T
H
17 biased
. The Prostate 72:11, pages 1239-1247.
Crossref
Crossref
Masoud H ManjiliKayvan Najarian & Xiang-Yang Wang. (2012) Signatures of tumor–immune interactions as biomarkers for breast cancer prognosis. Future Oncology 8:6, pages 703-711.
Crossref
Crossref
ZAKI SHAIKHIBRAHIM, ANDREAS LINDSTROT, REINHARD BUETTNER & NICOLAS WERNERT. (2011) Regulation of prostate cancer immunity-related genes in PC3 prostate cancer cells by ETS-1. Oncology Letters 3:3, pages 513-516.
Crossref
Crossref
Valerie Chew, Han Chong Toh & Jean-Pierre Abastado. (2012) Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy. Journal of Oncology 2012, pages 1-10.
Crossref
Crossref
Maria Libera Ascierto, Valeria De Giorgi, Qiuzhen Liu, Davide Bedognetti, Tara L Spivey, Daniela Murtas, Lorenzo Uccellini, Ben D Ayotte, David F Stroncek, Lotfi Chouchane, Masoud H Manjili, Ena Wang & Francesco M Marincola. (2011) An immunologic portrait of cancer. Journal of Translational Medicine 9:1.
Crossref
Crossref
Gianluca Bontempi, Benjamin Haibe-Kains, Christine Desmedt, Christos Sotiriou & John Quackenbush. (2011) Multiple-input multiple-output causal strategies for gene selection. BMC Bioinformatics 12:1.
Crossref
Crossref
Laurence Zitvogel, Oliver Kepp & Guido Kroemer. (2011) Immune parameters affecting the efficacy of chemotherapeutic regimens. Nature Reviews Clinical Oncology 8:3, pages 151-160.
Crossref
Crossref
Laurence Zitvogel, Oliver Kepp, Laetitia Aymeric, Yuting Ma, Clara Locher, Nicolas F. Delahaye, Fabrice André & Guido Kroemer. (2010) Integration of Host-Related Signatures with Cancer Cell–Derived Predictors for the Optimal Management of Anticancer Chemotherapy. Cancer Research 70:23, pages 9538-9543.
Crossref
Crossref
Joel F. Aldrich, Devin B. Lowe, Michael H. Shearer, Richard E. Winn, Cynthia A. Jumper & Ronald C. Kennedy. (2010) Vaccines and Immunotherapeutics for the Treatment of Malignant Disease. Clinical and Developmental Immunology 2010, pages 1-12.
Crossref
Crossref